Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Chemical and Biological Therapeutic Approaches to Neurological Disorders III
Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
199 Outcomes after microvascular decompression for patients with trigeminal neuralgia and suspected multiple sclerosis.
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
Opinion: Sex inclusion in basic research drives discovery.
Boxed warning of HBV risk added to Rituxan, Arezerra
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
Gray matter SWI-filtered phase and atrophy are linked to disability in MS .
Nanoparticle transport across the blood brain barrier.
Glatiramer acetate (GA) prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway.
American Society for Neurochemistry Annual Meeting
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Limit cycle oscillations in standing human posture.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.

Pages